Reference values of bone mineral density and prevalence of osteoporosis in Chinese adults

来源 :第七届国际骨质疏松及骨矿盐疾病学术会议 | 被引量 : 0次 | 上传用户:xbh88
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background: Well-accepted reference value of bone mineral density (BMD) is lacking in Chinese.We established the reference database and assessed osteoporosis prevalence based on published literature conducted in the Mainland China,Taiwan and Hong Kong Chinese.
其他文献
Background: Bisphosphonates (BPs) are therapeutic agents for treatment of bone disorders such as osteoporosis and Paget s disease.Several nitrogen-containing bisphosphonates (N-BPs) and phosphonocarbo
会议
Background: Increased vascular permeability is one of the first stages in both physiological and pathological angiogenesis.Osteoporosis accompanies with reduced angiogenesis and vascularization.Howeve
会议
Monocyte chemotactic protein-1 (MCP-1) belongs to the CC chemokine superfamily (as CCL2).It plays a critical role in recruitment and activation of leukocytes during acute inflammation, and has the hig
会议
In recent years the CreER transgenic approach has been widely used for lineage tracing and functional studies.Using Osx-CreER and Nes-CreER transgenic mice, distinct osteoblast progenitor cell populat
会议
Background: Fat infiltration within marrow cavity is one of multitudinous features of estrogen deficiency, which leads to a decline in bone formation functionality.The origin of this fat is unclear, b
会议
Background: Previous studies have reported statins showed positive effects on bone in human and animal models.This study was to investigate the effects of atorvastatin in the prevention of osteoporosi
会议
Background: Casein kinase-2 interacting protein-1 (CKIP1) specifically targets the linker region between the WW domains of smad ubiquitination regulatory factor 1 (Smurf 1) to promote its ubiquitylati
会议
Background: The loss of estrogen at menopause causes the increasing bone-resorbing activity of osteoclasts to outpace the bone-forming activity of osteoblasts, always leading to the occurrence of post
会议
Background: Ipriflavone (IP), a synthesized derivative of isoflavone, has become an over-the-counter drug for prevention of osteoporosis (OP) since 1989 in over 22 countries.Although clinical trials h
会议
Background: Osteogenesis imperfecta (OI) type Ⅴ is rare,autosomal dominant inherited disease characterized by multiple fractures, radial head dislocation, intraosseous membrane calcification of the fo
会议